Transition in biology and philosophy in the treatment of gastroesophageal junction adenocarcinoma

Journal of Clinical Oncology

Volumn 27, Issue 6, 2009, Pages 836-837

  Tepper, Joel E ^a   O'Neil, Bert ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID;

ALCOHOL CONSUMPTION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHRONIC GASTRITIS; CLINICAL TRIAL; DISEASE CLASSIFICATION; EDITORIAL; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HUMAN; LOWER ESOPHAGUS SPHINCTER; OBESITY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; SMOKING; TREATMENT DURATION;

ADENOCARCINOMA; CLINICAL TRIALS AS TOPIC; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; HUMANS; RESEARCH DESIGN; STOMACH NEOPLASMS;

EID: 60849094487     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.5982     Document Type: Editorial

References (13)

1. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730, 2001
2. Cunningham D, Allum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20, 2006
3. Siewert JR, Stein HJ: Classification of adenocarcinoma of the oesophago-gastric junction. Br J Surg 85:1457-1459, 1998
4. Pedrazzani C, de Manzoni G, Marrelli D, et al: Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg 134:378-385, 2007
5. Krasna MJ, Tepper J: The role of multimodality therapy for esophageal cancer. Chest Surg Clin N Am 10:591-603, 2000
6. Urschel JD, Vasan H: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185:538-543, 2003
7. Urschel JD, Vasan H, Blewett CJ: A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 183:274-279, 2002
8. Malthaner RA, Wong RK, Rumble RB, et al: Neoadjuvant or adjuvant therapy for resectable esophageal cancer: A systematic review and meta-analysis. BMC Med 2:35, 2004
9. Kaklamanos IG, Walker GR, Ferry K, et al: Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: A meta-analysis of randomized clinical trials. Ann Surg Oncol 10:754-761, 2003
10. Fiorica F, Di Bona D, Schepis F, et al: Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis. Gut 53:925-930, 2004
11. Geh JI, Bond SJ, Bentzen SM, et al: Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: Evidence of a radiation and chemotherapy dose response. Radiother Oncol 78:236-244, 2006
12. Stahl M, Walz MK, Stuschke M, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851-856, 2009
13. Kelsen DP, Ginsberg R, Pajak TF, et al: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979-1984, 1998